Promino Nutritional Sciences Inc.
MUSL
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 317.33% | 718.00% | 583.23% | 199.21% | 11.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 317.33% | 718.00% | 583.23% | 199.21% | 11.06% |
| Cost of Revenue | 128.49% | 182.83% | 55.32% | -39.78% | -60.03% |
| Gross Profit | 219.67% | 232.81% | 119.56% | 91.73% | 81.67% |
| SG&A Expenses | -17.18% | -46.44% | -93.63% | -79.17% | -40.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.52% | -27.49% | -81.45% | -71.36% | -43.80% |
| Operating Income | 31.27% | 56.26% | 94.87% | 80.17% | 46.81% |
| Income Before Tax | 38.40% | 58.92% | 90.53% | 67.21% | 42.45% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 38.40% | 58.92% | 90.53% | 67.21% | 42.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.40% | 58.92% | 90.53% | 67.21% | 42.45% |
| EBIT | 31.27% | 56.26% | 94.87% | 80.17% | 46.81% |
| EBITDA | -- | -- | 110.89% | 94.56% | 54.98% |
| EPS Basic | 66.52% | 80.55% | 96.23% | 85.56% | 66.49% |
| Normalized Basic EPS | 55.06% | 75.93% | 95.04% | 87.76% | 70.10% |
| EPS Diluted | 63.44% | 78.70% | 96.26% | 84.72% | 65.58% |
| Normalized Diluted EPS | 55.06% | 75.93% | 95.04% | 87.76% | 70.10% |
| Average Basic Shares Outstanding | 44.01% | 58.59% | 94.78% | 70.91% | 60.81% |
| Average Diluted Shares Outstanding | 44.01% | 58.59% | 94.78% | 70.91% | 60.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |